7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions

This publication has 32 references indexed in Scilit:

• Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis
  Neurobiology of Disease, 2024
• Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems
  European Journal of Medicinal Chemistry, 2021
• A Triazolotriazine‐Based Dual GSK‐3β/CK‐1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition
  ChemMedChem, 2018
• Synthesis of 4‐Quinolones: N,O‐Bis­(trimethylsilyl)acetamide‐Mediated Cyclization with Cleavage of Aromatic C–O Bond
  European Journal of Organic Chemistry, 2016
• Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties
  Bioorganic & Medicinal Chemistry Letters, 2013
• Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies
  Neurobiology of Disease, 2012
• Identification of casein kinase-1 phosphorylation sites on TDP-43
  Biochemical and Biophysical Research Communications, 2009
• Combining docking and molecular dynamic simulations in drug design
  Medicinal Research Reviews, 2006
• High throughput artificial membrane permeability assay for blood–brain barrier
  European Journal of Medicinal Chemistry, 2003
• Characterization of the Cellular Reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular Localization, Substrate Dependence, and Involvement of Mitochondrial Electron Transport in MTT Reduction
  Archives of Biochemistry and Biophysics, 1993